Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Abbott Begins Enrollment in XIENCE 28 GLOBAL DAPT Trial
News | Antiplatelet and Anticoagulation Therapies | February 13, 2018

February 13, 2018 — Abbott announced the first patient has been enrolled in a...

Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018

February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the...

Baxter Announces FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin
Technology | Antiplatelet and Anticoagulation Therapies | January 22, 2018

January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of...

News | Antiplatelet and Anticoagulation Therapies | January 19, 2018

January 19, 2018 — The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is...

News | Business | January 16, 2018

January 16, 2018 — American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be...

New Oral Anticoagulant Drugs Associated with Lower Kidney Risks
News | Antiplatelet and Anticoagulation Therapies | December 12, 2017

December 12, 2017 — Mayo Clinic researchers have shown a link between which type of...

News | Antiplatelet and Anticoagulation Therapies | November 16, 2017

November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes...

News | Heart Failure | November 13, 2017

November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop...

Six Months of DAPT Non-Inferior to Twelve in STEMI Patients Receiving Drug-Eluting Stents
News | Antiplatelet and Anticoagulation Therapies | November 06, 2017

November 6, 2017 —  The first trial to evaluate the safety of...

Synergy Stent With Shorter DAPT Superior to Bare-Metal Stent in Elderly Patients
News | Stents Drug Eluting | November 06, 2017

November 6, 2017 — Elderly patients undergoing...

Statins Attributed With 10-Year Cholesterol Drop for Malaysian Heart Attack Patients
News | Antiplatelet and Anticoagulation Therapies | November 03, 2017

November 3, 2017 — A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests...

Three-Month DAPT Non-Inferior for ACS Patients Treated With Combo Dual Therapy Stent

Image courtesy of OrbusNeich

News | Stents Drug Eluting | November 01, 2017

November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at...

FDA Approves COBRA REDUCE Trial of 14-Day DAPT With CeloNova Stent
News | Stents | October 27, 2017

October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved...

News | Stem Cell Therapies | October 24, 2017

October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate...

Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017

October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...

Overlay Init